SPECIAL CONSIDERATIONS WHEN USING GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY AND DIABETES MELLITUS TYPE 2 IN OLDER ADULTS

Descargar Publicación
Crosstalk between sleep disorders and adipokine secretory profiles: novel mechanisms for metabolic disease risk